Marc Stuart Page

Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium.

Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France.

Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen.

Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Group is a British company that manufactures and distributes pharmaceutical products. The company is based in London, UK.

Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceutical Development Ltd. is a British company that engages in research and development of pharmaceutical products. The company is based in London, UK. Founded in 1990.

Founded in 2005, Shire Biopharmaceuticals Holdings is an investment holding British company that is part of Takeda Pharmaceutical Co., Ltd. The company is based in London, UK.

Part of Takeda Pharmaceutical Co., Ltd., Shire Global Finance is a British financial services company founded in 2005. The company is based in London, UK. Shire Global Finance offers financial services.

Part of Takeda Pharmaceutical Co., Ltd., Auralis Ltd. is a British company that develops and manufactures pharmaceutical products. The company is based in London, UK. The company was founded in 2005 by Simon Peter Bryson. Auralis was acquired by Shire ViroPharma, Inc., part of Takeda Pharmaceutical Co., Ltd. from January 27, 2014 on May 28, 2010 for $28.95 million.